Skip to content
Heavy Metal Index

The Toxicological Risk Assessment of Dermal Exposure of Patients

Source

This source page is a mechanical bulk-ingest record for a PDF in the research-pulls corpus.

Page snapshot
Cited by9 pages
Metals measured4
Evidence tierB
Year2021

Overview

This source page is a mechanical bulk-ingest record for a PDF in the research-pulls corpus. It preserves source-level identity, routeable product/analyte scope, and exact extracted numeric lines for later human or fresh-context audit. It does not derive HMTc thresholds, percentiles, or brand-by-brand comparisons.

Key numbers

The worker extracted the full PDF text with layout preservation twice and compared extraction hashes before commit. The following lines are copied from numeric/table-bearing regions of the PDF and retain the source units and wording where legible:

  • into account application of the parenteral PDE (100% of
  • study is described shortly in Table 1.
  • digested with 5.0 mL of concentrated nitric acid (63%). The
  • Table 1 Short description of analyzed samples
  • ple A: 178.84 ± 6.85 μg/kg for Ni and 254.13 ± 12.59 μg/ tigated metallic elements in this kind of pharmaceuticals
  • D (56.51 ± 3.22 μg/kg), and the lowest content of Cr was this situation is actual level in the one-time administration
  • in sample C (21.16 ± 3.75 μg/kg). The nickel levels were (single dose) of the product (approximately 0.20 g). The
  • (21.157–254.13 μg/kg). It can be assumed that in general, exposure of investigated elements (the maximum daily
  • Ni levels were approximately similar (mean = 92.11 μg/ dose of applied pharmaceuticals).
  • kg) to Cr levels (mean = 118.97 μg/kg).
  • Medicines Agency (EMA) as 35 μg/kg (1). Analysis of the ointments were calculated considering the maximum use
  • obtained results shows that CTCL value was exceeded in during the day — Table 3. We use five applications as rec-
  • uct poses a potential allergic risk due to Ni content. For from Table 3.
  • Cr assessment, additional approaches due to sensitization Results from Table 3 show that the estimated exposure of
  • Table 2 The levels of nickel and chromium in analyzed samples Table 3 The estimated daily exposure of investigated metals in ana-
  • Table 4 The calculations of cutaneous permitted daily exposure Conclusions and Recommendations
  • the CTCL (> 35 μg/kg). This indicates a potential allergy
  • parenteral PDE, which assumed 100% bioavailability, to gle dose of applied ointment, again, is also at a very low
  • skin 10; 100%/10% = 10) — Eq. 1. dermal route. The toxicological risk assessment approach
  • shown in Table 4. patients. It should be emphasized that there is a potential

Methods (brief)

  • assessment. The toxicological analysis was carried out using microwave-assisted wet digestion with concentrated nitric acid
  • and electrothermal atomization atomic absorption spectrometry. Our results show that the ointments with Marjoram herb
  • Abbreviations ET AAS Electrothermal atomization atomic absorption
  • OTC Samples and Preparation
  • The samples were traditional herbal medicinal products used for
  • methodological standards, all samples were coded (as A, B,
  • wave digestion. After this step, all samples were digested
  • using microwave digestion system. Five replications were
  • Table 1 Short description of analyzed samples
  • B kept and done for all samples. The detailed information
  • about digestion procedure and all instrumental parameters
  • ized water. The cooled samples were stored in plastic bottles
  • as stock sample solutions until analysis.
  • was based on our studies published earlier (7, 10). Five data of five independent replicates (five replicate samples
  • replications were performed for each sample. The qual- from one tube of each preparation) were expressed as the
  • medical products samples (A,
  • kg for chromium. The lowest content of Ni was in sample should include more information. Required information in
  • in sample C (21.16 ± 3.75 μg/kg). The nickel levels were (single dose) of the product (approximately 0.20 g). The

Implications

This page makes the source discoverable for category-level evidence routing. Values remain source-native and should be used only with the stated matrix, species, basis, geography, and censoring context from the paper. The page does not convert total mercury to methylmercury or use total arsenic as inorganic arsenic.

Wiki pages this source may touch

Verification notes

  • Identity check: DOI, raw handle, candidate cite-key, and SHA-256 were compared against existing wiki/sources/ pages before creation.
  • Full-PDF read: pdftotext -layout was run on the full PDF twice; extracted text hashes matched before the page was written.
  • Numeric verification: numeric/table-bearing lines were selected mechanically from the verified extraction and preserved without unit conversion or rounding.
  • Brand firewall: the worker skips PDFs when extracted numeric lines appear brand/manufacturer-sensitive; this page contains category-level or species-level evidence only.
  • HMTc firewall: no threshold, percentile, pass/fail, clean/dirty, or certification math is stated.

Update history

The five most recent substantive edits to this page, classified major (evidence or structure moved), correction (a published value or statement was wrong and has been fixed), or minor (narrative rewritten without changing the underlying evidence). Each description is derived from what the edit did to this page; the linked commit is the authoritative record, routine regeneration passes are excluded, and the full version history lives in git. When DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.

CommitDateChangeDescription
b01ec52c2026-08-04major2 sections added
d49e450f2026-08-03major5 sections added; narrative text revised